Listed in Shenzhen Stock market under listing tick 0000627, Hubei Biocause Pharmaceutical Co., Ltd is the largest producer of bulk Ibuprofen powder and tablets in China with a capacity of 3000 metric tons and 4 billion tablets. The co***ny produces thousands of metric tons of bulk Ibuprofen substance and supplies to pharmaceutical co***nies from over 46 countries worldwide. It has six manufacturing sites and three research facilities. The co***ny employs about 1800.
One of its largest plants, the Jingmen facility built in 1993, occupies 140 acres of industrial land. Designed to produce bulk pharmaceutical active ingredients and other fine chemicals under international standards, the plant meets the latest local health, safety and environmental regulations, and is capable of producing 100 gm to 3000 metric tons of API or intermediates at 8 GMP workshops under Q7A guidelines.
Biocause has in place a quality assurance system, staffed by well trained and experienced personnel, which supports the compliance of co***ny's GMP operations.
The chemical processes for APIs and intermediates are developed in Biocause's research facilities, then transferred to Biocause's pilot and manufacturing facilities for scale-up and production.
|
Home
